SecBot SecBot
SECBOTREPLAY Home › Report › ONCY

ONCY · Oncolytics Biotech's S-3 shelf registration has become effective,…

ONCOLYTICS BIOTECH INC · EFFECT filed Apr 6, 2026 at 00:15 ET

At the news

BEARISHIMPACT 6/10

EFFECT filed Apr 6, 2026 at 00:15 ET

Oncolytics Biotech's S-3 shelf registration has become effective, allowing the company to issue up to $250 million in securities, including common stock, preferred stock, warrants, and other instruments. This follows a recent shelf filing and enables the company to raise capital opportunistically, creating a potential overhang of future dilution. The effectiveness date was April 3, 2026.

  • S-3 shelf registration became effective on April 3, 2026
  • Company may offer up to $250 million in securities, including common stock, preferred stock, warrants, purchase contracts, and units
  • Shelf registration allows for opportunistic capital raises over time
  • Prior shelf registration had $139 million in unsold capacity carried forward

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access